BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8532 related articles for article (PubMed ID: 1409445)

  • 1. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
    Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
    Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59.
    Takeda A; Tomita Y; Matsunaga J; Tagami H; Shibahara S
    J Biol Chem; 1990 Oct; 265(29):17792-7. PubMed ID: 2120217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA; Oetting WS
    Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human oculocutaneous albinism caused by single base insertion in the tyrosinase gene.
    Tomita Y; Takeda A; Okinaga S; Tagami H; Shibahara S
    Biochem Biophys Res Commun; 1989 Nov; 164(3):990-6. PubMed ID: 2511845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
    Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.
    Oetting WS; Mentink MM; Summers CG; Lewis RA; White JG; King RA
    Am J Hum Genet; 1991 Jul; 49(1):199-206. PubMed ID: 1905879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism.
    Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST
    Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS; King RA
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analyses of a tyrosinase-negative albino family.
    Park KC; Chintamaneni CD; Halaban R; Witkop CJ; Kwon BS
    Am J Hum Genet; 1993 Feb; 52(2):406-13. PubMed ID: 8430701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosinase gene mutations causing oculocutaneous albinisms.
    Tomita Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):186S-190S. PubMed ID: 8433007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 427.